登录 +0086-27-65522453 [email protected]

Elvitegravir(GS-9137) 编号 : 52022

化学信息

产品英文名称Elvitegravir(GS-9137)
Iupac 化学名称(S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
同义词JTK-303 
英文同义词JTK-303 
分子式C23H23ClFNO5 
分子量447.88 
SmileClC=1C(=C(CC=2C=C3C(C(=CN(C3=CC2OC)[[email protected]](CO)C(C)C)C(=O)O)=O)C=CC1)F
InChiKeyJUZYLCPPVHEVSV-LJQANCHMSA-N
InChiInChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1
Cas697761-98-1

技术数据

外观off-white solid 
纯度98% 
可溶性5mg/ml in DMSO 
存储3 years -20ºCpowder 6 months-80ºCin solvent 
运输条件Shipped under ambient temperature 
质量控制

产品详情

Elvitegravir (EVG, formerly GS-9137) is an integrase inhibitor used to treat HIV infection.It was developed by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. The drug gained approval by the U.S. FDA on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild.

 

结构

52022 - Elvitegravir(GS-9137) | CAS 697761-98-1

包装

规格价格
登录 to get price

快速订购

Change

联系我们